Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo

Sunkyu Kim, Qing Li, Chi V. Dang, Linda A. LeeProceedings of the National Academy of Sciences 2000 · DOI

TL;DR

This paper investigates the in vivo effects of c-Myc, a key regulator of cell growth and proliferation, in primary mouse liver cells. They found that transient c-Myc overexpression leads to hepatocyte hypertrophy (enlargement) and increased ribosomal gene expression, but without significant cell proliferation or apoptosis, suggesting a role for c-Myc in controlling cell size and metabolism independent of cell division.

What Problem Does This Paper Address?

The transcription factor c-Myc is a well-established driver of cell proliferation, differentiation inhibition, and transformation, particularly in immortalized cell lines. However, its role in primary cells in vivo has been less clear, with some evidence suggesting its effects might differ. Specifically, the authors wanted to understand the immediate consequences of c-Myc overexpression in a primary cell system in vivo, moving beyond the complexities of immortalized cell lines or long-term transgenic models where compensatory genetic changes can occur. They aimed to dissect whether c-Myc's known proliferative effects are its sole function or if it also plays a role in regulating cell mass and metabolism independently.

Methods

The researchers employed a recombinant adenovirus-mediated gene delivery system to transiently overexpress human c-Myc in the livers of adult mice.

  • Adenoviral Transduction: Mice were injected intravenously with adenoviruses encoding either human MYC (Ad/Myc), E2F-1 (a known cell cycle regulator, Ad/E2F-1), or β-galactosidase (Ad/LacZ, as a control).
  • Gene and Protein Expression Analysis: Northern and Western blots were used to confirm the expression of the introduced MYC transgene and protein, as well as the control E2F-1.
  • Histological Analysis: Hematoxylin and eosin (H&E) staining was used to visualize general tissue morphology. Methyl green pyronin staining was employed to differentiate RNA (red) from DNA (blue), highlighting nucleoli.
  • Cell Proliferation and Apoptosis Assays: Immunohistochemistry for the proliferation marker Ki-67 and TUNEL staining for apoptosis were performed on liver sections.
  • Cell Morphometrics: Image analysis software was used to quantify hepatocyte size and number per field.
  • Gene Expression Profiling: Northern blot analysis was used to assess the expression levels of specific ribosomal and nucleolar genes.

Datasets

Not discussed in the paper. The study primarily uses in vivo mouse models and analyzes tissue samples.

Key Insights and Ideas

  • c-Myc drives hypertrophy, not proliferation, in primary hepatocytes: This is a major departure from observations in immortalized cells. The enlarged hepatocytes were not undergoing significant cell division.
  • Ribosomal gene upregulation is key to hypertrophy: The increased cell size was strongly correlated with the upregulation of genes involved in ribosomal biogenesis and protein synthesis, suggesting c-Myc directly promotes the machinery for building cellular mass.
  • c-Myc's role in cell size is separable from proliferation: The use of Ad/E2F-1 as a control demonstrated that other cell cycle regulators don't induce hypertrophy, highlighting the specificity of c-Myc's effect on cell mass.
  • In vivo primary cell models are crucial: The study underscores the limitations of immortalized cell lines for fully understanding c-Myc's function, as primary cells exhibit distinct responses.
  • Nucleolar enlargement as a marker: Prominent nucleoli in c-Myc-overexpressing hepatocytes served as a visual indicator of increased ribosomal activity.

Key Results

  • Hepatocyte Enlargement: Ad/Myc-injected mice showed a ~2-fold increase in hepatocyte volume compared to Ad/LacZ controls.
  • Absence of Proliferation: Despite enlarged cells, Ki-67 staining indicated minimal increase in hepatocyte proliferation (less than 0.03% of hepatocytes were positive).
  • Low Apoptosis: While there was a slight increase in apoptotic cells in Ad/Myc livers (7% vs. 2% in controls), the majority of enlarged hepatocytes were not undergoing apoptosis.
  • Ribosomal Gene Upregulation: Northern blots confirmed increased expression of several large- and small-subunit ribosomal genes, as well as nucleolar proteins like nucleophosmin and nucleolin, in Ad/Myc livers.
  • Specificity of c-Myc Effect: Overexpression of E2F-1 did not lead to hepatocyte enlargement, confirming the effect was specific to c-Myc.

Limitations and Future Work

  • Transient Expression: The study focused on immediate effects of transient c-Myc expression. Long-term consequences or the impact of sustained expression were not assessed.
  • Model Specificity: While the liver model is robust, the findings might not directly translate to all cell types or tissues.
  • Gene 33 Downregulation: The study noted the downregulation of "gene 33," a hormonally regulated gene involved in cell proliferation and regeneration, suggesting c-Myc can have complex, context-dependent effects on gene expression.
  • Future Directions: The authors suggest further investigation into the specific mechanisms by which c-Myc regulates ribosomal genes and protein synthesis. They also highlight the need to understand how these in vivo findings, particularly the hypertrophy independent of proliferation, relate to cell transformation and tumorigenesis, especially given that enlarged nucleoli are a hallmark of cancer cells. Determining if this gene expression pattern differs from that implicated in cell proliferation is also a key area for future research.

Summary updated

Abstract

Overexpression of c-Myc in immortalized cells increases cell proliferation, inhibits cell differentiation, and promotes cell transformation. Recent evidence suggests that these effects, however, do not necessarily occur when c-Myc is overexpressed in primary mammalian cells. We sought to determine the immediate effects of transient overexpression of c-Myc in primary cells in vivo by using recombinant adenovirus to overexpress human MYC in mouse liver. Mice were intravenously injected with adenoviruses encoding MYC (Ad/Myc), E2F-1 (Ad/E2F-1), or beta-galactosidase (Ad/LacZ). Transgene expression was detectable 4 days after injection. Expression of ectopic c-Myc was immediately accompanied by enlarged and dysmorphic hepatocytes in the absence of significant cell proliferation or apoptosis. These findings were not present in the livers of mice injected with Ad/E2F-1 or Ad/LacZ. Prominent hepatocyte nuclei and nucleoli were associated with the up-regulation of large- and small-subunit ribosomal and nucleolar genes, suggesting that c-Myc may induce their expression to increase cell mass. Our studies support a role for c-Myc in the in vivo control of vertebrate cell size and metabolism independent of cell proliferation.
BibTeX
@inproceedings{kim2000induction,
  author = {Sunkyu Kim and Qing Li and Chi V. Dang and Linda A. Lee},
  title = {{Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc <i>in vivo</i>}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2000},
  doi = {10.1073/pnas.200372597},
}
Figure